Results 91 to 100 of about 5,730 (195)

Scleral Thickening as an Etiology for Optic Disc edema in Hunter Syndrome

open access: yes, 2023
Hunter syndrome is a Type II mucopolysaccharidoses (MPS) metabolic disorder that is defined by a deficiency of iduronate-2-sulfatase, leading to a buildup of glycosaminoglycans (GAGs) and clinical features such as developmental delay and facial ...
Terisa Yiin; Nandini Gandhi; Yin Liu
core  

Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N -acetylgalactosamine-6-sulfate sulfatase (GALNS)

open access: yes, 2017
Maturation of type I sulfatases requires the conversion of the cysteine (Cys) or serine (Ser) present in the active site to formylglycine (FGly). This activation represents a limiting step during the production of recombinant sulfatases in bacteria and ...
Bonilla Y.A.   +17 more
core   +1 more source

Mass spectroscopy results of proteins interacting exclusively with POC5A429V.

open access: yes, 2019
Five proteins were found to be interacting exclusively with POC5A429. Protein disulfide-isomerase A4, Iduronate 2-sulfatase, Golgi resident protein GCP60, Aminopeptidase B and cDNA FLJ53442; highly similar to Poly (ADP-ribose) polymerase.
Charlotte Zaouter (182378)   +9 more
core   +1 more source

遺伝性ムコ多糖代謝異常症II型 (Hunter病) の分子生物学的研究 I) Intermediate form of mucopolysaccharidosis type II (Hunter disease) : a C^<1327> to T substitution in the iduronate sulfatase gene. II) Mucopolysaccharidosis type II (Hunter disease) : identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.

open access: yes
博士論文 (Doctoral dissertation)I) Intermediate form of mucopolysaccharidosis type II (Hunter disease) : a C^ to T substitution in the iduronate sulfatase gene.II) Mucopolysaccharidosis type II (Hunter disease) : identification and characterization of eight ...
祐川, 和子
core  

Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report

open access: yesMolecular Genetics and Metabolism Reports
Mucopolysaccharidosis II (MPS II) is a lysosomal storage disease caused by a deficiency in iduronate-2-sulfatase (IDS), leading to the accumulation of dermatan sulfate and heparan sulfate in lysosomes.
Yusuke Hattori   +5 more
doaj   +1 more source

Mean CSF I2S concentration-time profiles.

open access: yes, 2015
After intravenous and IT-L dosing, mean CSF I2S concentration-time profiles were determinedwith CSF sampled at the CM level (A) and at the IT-L level (B). Error bars represent standard deviation. CSF, cerebrospinal fluid; I2S, iduronate-2-sulfatase; IT-L,
Hongsheng Xie (716868)   +3 more
core   +1 more source

The diagnosis and management of mucopolysaccharidosis type II

open access: yesItalian Journal of Pediatrics
Mucopolysaccharidosis type II (MPS II) is a rare X-linked recessive inherited lysosomal storage disease. With pathogenic variants of the IDS gene, the activity of iduronate-2-sulfatase (IDS) is reduced or lost, causing the inability to degrade ...
Shao-Jia Mao   +4 more
doaj   +1 more source

Attenuated Hunter Syndrome

open access: yes, 2015
Hunter Syndrome (HS) is a multisystemic disorder characterized by glycosaminoglycan (GAG) accumulation due to enzyme deficiency of iduronate 2-sulfatase.
Kannan Narayana; Lau Heather; Rachel Nolan; Rucker Janet; Balcer Laura; Galetta Steven
core  

Mucopolysaccharidosis type II and the G374sp mutation

open access: yes, 2013
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare, X-linked disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyses a step in the catabolism of glycosaminoglycans resulting in ...
Martínez-Quintana, E.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy